PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24602049-2	2014	This study aimed to evaluate the effect of gene polymorphisms of CYP2C9, VKORC1, thrombomodulin (THBD) and C-reactive protein (CRP) on the risk of bleeding complications of warfarin at therapeutic INR in Korean patients with mechanical cardiac valves.	Warfarin	173-181	C-reactive protein	Homo sapiens	107-125	
24602049-2	2014	This study aimed to evaluate the effect of gene polymorphisms of CYP2C9, VKORC1, thrombomodulin (THBD) and C-reactive protein (CRP) on the risk of bleeding complications of warfarin at therapeutic INR in Korean patients with mechanical cardiac valves.	Warfarin	173-181	C-reactive protein	Homo sapiens	127-130	
24602049-13	2014	In contrast, our results suggest that two genetic markers (THBD rs1042580 and CRP rs1205) could be predictors of bleeding complications of warfarin at normal INR.	Warfarin	139-147	C-reactive protein	Homo sapiens	78-81	
24383779-7	2001	We treated the patient with prednisolone and warfarin, which resulted in an improvement in CRP levels and no thrombosis-related complications.	Warfarin	45-53	C-reactive protein	Homo sapiens	91-94